| Popis: |
There are several imaging devices routinely utilized for evaluation of chest wall tumors predominantly focused in determining the extent of tumor involvement and the potential for respectability. This comprises computed radiography (CR), ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), [F-18] FDG positron-emission tomography (PET)/CT, and [F-18] FDG PET/MRI. CR, CT, and MRI are the first line; of these MRI allows tissue characterization, accurate assessment of tumor extent, differentiation from adjacent inflammation, information of blood flow, diffusion capacity, texture features, and specification of metabolites within tumors. Imaging devices are also noninvasive methods which have revolutionized oncological imaging by combination of metabolic activities and morphologic features. They are also useful in guiding biopsy, evaluating patient prognosis, staging the disease, monitoring therapeutic response, and detecting recurrences in chest wall tumors. This leads to the appropriate management of patients with these masses. In vivo morphologic and metabolic information obtained by these several modalities plays an important role to manage patients with chest wall tumors. |
